QURE
Uniqure Nv
NASDAQ · Biotechnology
$25.65
+1.13 (+4.61%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 34.34M | 92.13M | 362.13M | 366.27M | 316.03M |
| Net Income | -303,349,284 | -732,531,139 | 45.68M | 43.81M | 38.10M |
| EPS | — | — | — | — | — |
| Profit Margin | -883.4% | -839.2% | 12.6% | 12.0% | 12.1% |
| Rev Growth | -62.7% | -62.7% | +18.7% | -4.9% | -4.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 556.90M | 556.90M | 223.89M | 204.81M | 207.31M |
| Total Equity | 233.17M | 233.17M | 885.03M | 806.10M | 940.40M |
| D/E Ratio | 2.39 | 2.39 | 0.25 | 0.25 | 0.22 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -217,362,741 | -554,050,453 | 50.55M | 53.48M | 50.33M |
| Free Cash Flow | — | — | 25.33M | 19.66M | 18.73M |